Market News AIOpen the app

Cullinan Therapeutics shared new study results showing four patients with lupus had complete kidney recovery using velinotamig.

TrialRead the original at globenewswire.com
Good for CGEM

Cullinan reported 4 complete kidney responses, an encouraging sign for its lupus treatment. The study is still early and ongoing, so more testing must confirm the result.

CGEM · Cullinan Therapeutics, Inc.

AI read · Good for CGEM

The AI's read

This gives Cullinan an encouraging sign that its lupus treatment may help the kidneys. The study is still early and ongoing, so more testing must confirm the result.

Get alerts for CGEM

Follow Cullinan Therapeutics, Inc. (CGEM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CGEM
Free on the App Store and Google Play, or on the web.